During the past decade, Ruppiner Kliniken GmbH conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ruppiner Kliniken GmbH" #1 sponsor was "Celgene" with 3 trials, followed by "Charite University, Berlin, Germany" with 2 trials sponsored, "Biotronik SE & Co. KG" with 1 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored and "III. Medizinische Klinik Mannheim" with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ruppiner Kliniken GmbH" #1 collaborator was "German Federal Ministry of Education and Research" with 2 trials as a collaborator, "University of Leipzig" with 2 trials as a collaborator, "BARMER" with 1 trials as a collaborator, "Clinical Trials Unit Freiburg" with 1 trials as a collaborator and "Fraunhofer-Institut für Offene Kommunikationssysteme FOKUS, Berlin, Germany" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Ruppiner Kliniken GmbH" are "Crohn Disease" (3 trials), "Abdominal Wound Healing Disorder" (1 trials), "Abdominal Wound Healing Impairment" (1 trials), "Acute Myocardial Infarction" (1 trials) and "Acute Postsurgical Subcutaneous Wound" (1 trials). Many other conditions were trialed in "Ruppiner Kliniken GmbH" in a lesser frequency.

Most popular intervention types in "Ruppiner Kliniken GmbH" are "Drug" (10 trials), "Other" (5 trials), "Device" (4 trials), "Radiation" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ozanimod" (3 trials), "Placebo" (2 trials), "5-Fluorouracil" (1 trials), "Aripiprazole" (1 trials) and "Carboplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ruppiner Kliniken GmbH" are 16 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Ruppiner Kliniken GmbH". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Ruppiner Kliniken GmbH, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Ruppiner Kliniken GmbH, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".